 |
|
Researchers discover mechanism that may enable stem cell-based treatment for eye disorders
June 24, 2005UCI study shows how newly identified signaling protein helps control retinal development
Irvine, Calif.-In discovering a protein that helps organize the development of the retina, UC Irvine researchers have found a new molecular mechanism that may allow for stem cell-based therapies to treat eye disorders such as retinal degeneration.
The finding also reveals how the retina's own stem cells can be directed to aid the growth of new cells to replace diseased or dying ones in the eye. Study results appear in the June 24 issue of the journal Science.
Anne L. Calof in the Department of Anatomy and Neurobiology and her UCI colleagues have identified how a protein called GDF11 controls a key component of retinal-cell differentiation during development, which makes GDDF11 an attractive therapeutic target.
"By manipulating the ability of this protein to control cell development, there is the potential for therapeutics to harness the power of the stem cells that already exist in the retina to replace any retinal cells that have been lost or injured," Calof said. "If so, we thereby may be able to cure visual disorders that result from loss of certain retinal cell types."
During the process of embryonic development, groups of neural precursor cells, which are formed from stem cells, are given brief periods of time to differentiate into their specific tissue forms, a process that is tightly regulated by signaling proteins.
In tests on developing mice, the Calof group observed that the GDF11 protein precisely controls the "window of opportunity" in which retinal precursor cells differentiate into the cells that give rise to the optic nerve. This regulation is important, Calof said, because it assures proper development of the entire retina, a nerve cell layer that lines the back of the eye, senses light and creates the electrical impulses that travel through the optic nerve to the brain.
GDF11 is part of the superfamily of TGF-beta proteins, which are widely studied for their role both in human development and in diseases like cancer. Because the structure and properties of these proteins are well known, GDF11 is an especially attractive target for potential drug treatments.
Therapies based on this protein become possible, Calof said, because the retina contains its own stem cells, which among other things, generate the photoreceptors that allow us to see color. However, harvesting these cells for therapeutic purposes may not be feasible. While researchers have created ways to extract adult stem cells from the body, the process is difficult and rarely successful.
Rather than removing adult stem cells and reintroducing cultured ones into the eye, Calof said, a drug therapy based on the GDF11 protein may be able to harness the power of these endogenous stem cells by directing the differentiation of these cells into specific retinal cell types.
"The ultimate goal is to control how GDF11 and related proteins regulate the window of opportunity for neural cell growth," Calof said. "If we or other researchers can accomplish this, we will come one step closer to understanding how to manipulate neural stem cells for therapeutic good."
The research was supported by the National Institutes of Health and the March of Dimes Birth Defects Foundation. Joon Kim, Hsiao-Huei Wu and Arthur Lander of UCI, along with Karen Lyons of UCLA and Martin M. Matzuk of Baylor College of Medicine, participated in the study. UCI has filed a patent for use of GDF11 and related proteins and antagonists in treatment of retinal disorders.
University of California-Irvine
Anne L. Calof in the Department of Anatomy and Neurobiology and her UCI colleagues have identified how a protein called GDF11 controls a key component of retinal-cell differentiation during development, which makes GDDF11 an attractive therapeutic target.
"By manipulating the ability of this protein to control cell development, there is the potential for therapeutics to harness the power of the stem cells that already exist in the retina to replace any retinal cells that have been lost or injured," Calof said. "If so, we thereby may be able to cure visual disorders that result from loss of certain retinal cell types."
During the process of embryonic development, groups of neural precursor cells, which are formed from stem cells, are given brief periods of time to differentiate into their specific tissue forms, a process that is tightly regulated by signaling proteins.
In tests on developing mice, the Calof group observed that the GDF11 protein precisely controls the "window of opportunity" in which retinal precursor cells differentiate into the cells that give rise to the optic nerve. This regulation is important, Calof said, because it assures proper development of the entire retina, a nerve cell layer that lines the back of the eye, senses light and creates the electrical impulses that travel through the optic nerve to the brain.
GDF11 is part of the superfamily of TGF-beta proteins, which are widely studied for their role both in human development and in diseases like cancer. Because the structure and properties of these proteins are well known, GDF11 is an especially attractive target for potential drug treatments.
Therapies based on this protein become possible, Calof said, because the retina contains its own stem cells, which among other things, generate the photoreceptors that allow us to see color. However, harvesting these cells for therapeutic purposes may not be feasible. While researchers have created ways to extract adult stem cells from the body, the process is difficult and rarely successful.
Rather than removing adult stem cells and reintroducing cultured ones into the eye, Calof said, a drug therapy based on the GDF11 protein may be able to harness the power of these endogenous stem cells by directing the differentiation of these cells into specific retinal cell types.
"The ultimate goal is to control how GDF11 and related proteins regulate the window of opportunity for neural cell growth," Calof said. "If we or other researchers can accomplish this, we will come one step closer to understanding how to manipulate neural stem cells for therapeutic good."
The research was supported by the National Institutes of Health and the March of Dimes Birth Defects Foundation. Joon Kim, Hsiao-Huei Wu and Arthur Lander of UCI, along with Karen Lyons of UCLA and Martin M. Matzuk of Baylor College of Medicine, participated in the study. UCI has filed a patent for use of GDF11 and related proteins and antagonists in treatment of retinal disorders.
University of California-Irvine
Telescope embedded in glasses lens promises to make driving easier for visually impaired
Glasses embedded with a telescope promise to make it easier for people with impaired vision to drive and do other activities requiring sharper distance vision.
A crucial role for TGFbeta signaling in congenital eye disorders
The lens in the developing eye acts as a TGFbeta signaling center that controls differentiation, survival and formation of multiple eye structures deriving from the neural crest.
More Eye Disorders News Articles
 | Eye Movement Desensitization and Reprocessing (EMDR): Basic Principles, Protocols, and Procedures, 2nd Edition by Francine Shapiro This volume provides the definitive guide to Eye Movement Desensitization and Reprocessing (EMDR), the psychotherapeutic approach developed by Francine Shapiro. EMDR is one of the most widely investigated treatments for posttraumatic stress disorder, and many other applications are also being explored. To keep up with this growing body of knowledge, the second edition has been revised to... |
 | Eye Movement Disorders by Agnes Wong Eye Movement Disorders, by Dr. Agnes Wong, fills a great void in the Ophthalmology and Neurology literature by presenting eye movement disorders in a full-color, highly illustrative format. This text explains eye movement disorders in a concise yet comprehensive manner, which makes it an excellent reference book and an outstanding learning text for anyone trying to master the intricate... |
 | EMDR: The Breakthrough "Eye Movement" Therapy for Overcoming Anxiety, Stress, and Trauma by Francine Shapiro, Margot Silk Forrest Hailed as the most important method to emerge in psychotherapy in decades, EMDR has successfully treated psychological problems and illnesses in more than one million sufferers worldwide, with a rapidity that defies belief. In a new introduction, Shapiro presents the new applications of this remarkable therapy and the latest scientific research that demonstrates its... |
 | Intense Minds: Through the Eyes of Young People with Bipolar Disorder by Tracy Anglada Young people with bipolar disorder and adults who grew up with the condition speak out to share how they experienced the symptoms of this illness during their youth, and how it affected their functioning in school, at home and with friends. Their insightful comments, woven together by the author, form a stunning picture of the young person's internal experience. The reader will come away with a... |
 | Reversing Dry Eye Syndrome: Practical Ways to Improve Your Comfort, Vision, and Appearance (Yale University Press Health & Wellness) by Steven L. Maskin M.D. This clear, accessible book combines detailed medical information with expert treatment advice for the estimated twenty million Americans who suffer from dry eye syndrome. Dr. Steven L. Maskin, an ophthalmologist who has been caring for dry eye patients for more than fifteen years, explains exactly what the syndrome is, why it occurs, and how it can best be managed and treated. He dispels the... |
 | A Bird's-Eye View of Life with ADD and ADHD: Advice from young survivors by Chris A. Zeigler Dendy See information for first... |
 | Developing Ocular Motor and Visual Perceptual Skills: An Activity Workbook by Kenneth Lane With over 20 years of experience, Dr. Kenneth A. Lane has designed Developing Ocular Motor and Visual Perceptual Skills: An Activity Workbook to help occupational therapists, optometrists, and other professionals develop the ocular motor and visual perceptual skills of learning disabled children. To establish a framework for understanding, each chapter begins with the scientific theories used... |
 | Healing the Heart of Trauma and Dissociation with EMDR and Ego State Therapy by Ed Carol Forgash "This book pioneers the integration of EMDR with ego state techniques and opens new and exciting vistas for the practitioners of each." --From the foreword by John G. Watkins, PhD, founder of ego state therapy "This is a book about polypsychism and trauma. It offers a number of creative syntheses of EMDR with several models of polypsychism. It also surveys and includes many other models of... |
 | Medical-Surgical Nursing Certification Exam Review: Pearls of Wisdom by Scott H. Plantz, III, E. John Wipfler The best rapid, last-minute review for the CMSRN exam This is the most intense, targeted, and focused review available for anyone preparing for the Certified Medical-Surgical Nurse exam. You'll find 3,000 rapid-fire questions accompanied by the correct answer only, performance improving pearls, key facts, and mnemonics, visual imagery, and other tested learning aids. Written by experts who... |
 | Healing Your Eyes with Chinese Medicine: Acupuncture, Acupressure, & Chinese Herbs by Andy Rosenfarb For the past ten years, Andy Rosenfarb has successfully used acupuncture and Chinese medicine to treat a wide range of eye conditions. His treatments include moxibustion techniques, tuina (massage), microcurrent stimulation, Chinese herbs, and qigong exercises, along with “essential acupuncture” where essential oils are placed on acupuncture points. The culmination of his... |
| © 2008 BrightSurf.com |